nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—migraine—Cyproheptadine—allergic rhinitis	0.51	1	CpDpCtD
Dihydroergotamine—HTR6—Cyproheptadine—allergic rhinitis	0.093	0.249	CbGbCtD
Dihydroergotamine—HTR2B—Cyproheptadine—allergic rhinitis	0.0831	0.223	CbGbCtD
Dihydroergotamine—HTR1A—Cyproheptadine—allergic rhinitis	0.051	0.137	CbGbCtD
Dihydroergotamine—ABCB1—Desloratadine—allergic rhinitis	0.0227	0.0609	CbGbCtD
Dihydroergotamine—CYP3A4—Flunisolide—allergic rhinitis	0.0136	0.0365	CbGbCtD
Dihydroergotamine—ABCB1—Loratadine—allergic rhinitis	0.013	0.035	CbGbCtD
Dihydroergotamine—CYP3A4—Olopatadine—allergic rhinitis	0.0128	0.0343	CbGbCtD
Dihydroergotamine—ABCB1—Methylprednisolone—allergic rhinitis	0.0119	0.032	CbGbCtD
Dihydroergotamine—CYP3A4—Montelukast—allergic rhinitis	0.00781	0.021	CbGbCtD
Dihydroergotamine—CYP3A4—Loratadine—allergic rhinitis	0.00781	0.021	CbGbCtD
Dihydroergotamine—ABCB1—Betamethasone—allergic rhinitis	0.00776	0.0208	CbGbCtD
Dihydroergotamine—ABCB1—Prednisolone—allergic rhinitis	0.00765	0.0205	CbGbCtD
Dihydroergotamine—ABCB1—Hydrocortisone—allergic rhinitis	0.00726	0.0195	CbGbCtD
Dihydroergotamine—CYP3A4—Methylprednisolone—allergic rhinitis	0.00715	0.0192	CbGbCtD
Dihydroergotamine—CYP3A4—Triamcinolone—allergic rhinitis	0.00542	0.0145	CbGbCtD
Dihydroergotamine—CYP3A4—Betamethasone—allergic rhinitis	0.00465	0.0125	CbGbCtD
Dihydroergotamine—CYP3A4—Prednisolone—allergic rhinitis	0.00459	0.0123	CbGbCtD
Dihydroergotamine—ABCB1—Dexamethasone—allergic rhinitis	0.00451	0.0121	CbGbCtD
Dihydroergotamine—CYP3A4—Hydrocortisone—allergic rhinitis	0.00435	0.0117	CbGbCtD
Dihydroergotamine—CYP3A4—Dexamethasone—allergic rhinitis	0.0027	0.00725	CbGbCtD
Dihydroergotamine—Myocardial infarction—Prednisolone—allergic rhinitis	0.000119	0.00102	CcSEcCtD
Dihydroergotamine—Pruritus—Cetirizine—allergic rhinitis	0.000118	0.00101	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Prednisolone—allergic rhinitis	0.000118	0.00101	CcSEcCtD
Dihydroergotamine—Asthenia—Flunisolide—allergic rhinitis	0.000117	0.00101	CcSEcCtD
Dihydroergotamine—Dizziness—Loratadine—allergic rhinitis	0.000117	0.00101	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Hydrocortisone—allergic rhinitis	0.000117	0.001	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Triamcinolone—allergic rhinitis	0.000116	0.000998	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Hydrocortisone—allergic rhinitis	0.000116	0.000997	CcSEcCtD
Dihydroergotamine—Pruritus—Flunisolide—allergic rhinitis	0.000116	0.000996	CcSEcCtD
Dihydroergotamine—Muscular weakness—Dexamethasone—allergic rhinitis	0.000116	0.000994	CcSEcCtD
Dihydroergotamine—Muscular weakness—Betamethasone—allergic rhinitis	0.000116	0.000994	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000114	0.000982	CcSEcCtD
Dihydroergotamine—Diarrhoea—Cetirizine—allergic rhinitis	0.000114	0.00098	CcSEcCtD
Dihydroergotamine—Vomiting—Loratadine—allergic rhinitis	0.000113	0.000968	CcSEcCtD
Dihydroergotamine—Diarrhoea—Flunisolide—allergic rhinitis	0.000112	0.000964	CcSEcCtD
Dihydroergotamine—Rash—Loratadine—allergic rhinitis	0.000112	0.00096	CcSEcCtD
Dihydroergotamine—Dermatitis—Loratadine—allergic rhinitis	0.000112	0.000959	CcSEcCtD
Dihydroergotamine—Urticaria—Montelukast—allergic rhinitis	0.000111	0.000954	CcSEcCtD
Dihydroergotamine—Headache—Loratadine—allergic rhinitis	0.000111	0.000954	CcSEcCtD
Dihydroergotamine—Abdominal pain—Montelukast—allergic rhinitis	0.00011	0.00095	CcSEcCtD
Dihydroergotamine—Body temperature increased—Montelukast—allergic rhinitis	0.00011	0.00095	CcSEcCtD
Dihydroergotamine—Sweating increased—Dexamethasone—allergic rhinitis	0.00011	0.000949	CcSEcCtD
Dihydroergotamine—Sweating increased—Betamethasone—allergic rhinitis	0.00011	0.000949	CcSEcCtD
Dihydroergotamine—Dizziness—Cetirizine—allergic rhinitis	0.00011	0.000947	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Triamcinolone—allergic rhinitis	0.00011	0.000944	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Methylprednisolone—allergic rhinitis	0.00011	0.000942	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Triamcinolone—allergic rhinitis	0.000109	0.000939	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Methylprednisolone—allergic rhinitis	0.000109	0.000937	CcSEcCtD
Dihydroergotamine—Dizziness—Flunisolide—allergic rhinitis	0.000108	0.000931	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Triamcinolone—allergic rhinitis	0.000108	0.000931	CcSEcCtD
Dihydroergotamine—Vomiting—Cetirizine—allergic rhinitis	0.000106	0.000911	CcSEcCtD
Dihydroergotamine—Nausea—Loratadine—allergic rhinitis	0.000105	0.000904	CcSEcCtD
Dihydroergotamine—Epistaxis—Triamcinolone—allergic rhinitis	0.000105	0.000903	CcSEcCtD
Dihydroergotamine—Rash—Cetirizine—allergic rhinitis	0.000105	0.000903	CcSEcCtD
Dihydroergotamine—Dermatitis—Cetirizine—allergic rhinitis	0.000105	0.000902	CcSEcCtD
Dihydroergotamine—Visual impairment—Prednisolone—allergic rhinitis	0.000105	0.000901	CcSEcCtD
Dihydroergotamine—Headache—Cetirizine—allergic rhinitis	0.000104	0.000897	CcSEcCtD
Dihydroergotamine—Vomiting—Flunisolide—allergic rhinitis	0.000104	0.000895	CcSEcCtD
Dihydroergotamine—Rash—Flunisolide—allergic rhinitis	0.000103	0.000888	CcSEcCtD
Dihydroergotamine—Dermatitis—Flunisolide—allergic rhinitis	0.000103	0.000887	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Montelukast—allergic rhinitis	0.000103	0.000885	CcSEcCtD
Dihydroergotamine—Headache—Flunisolide—allergic rhinitis	0.000103	0.000882	CcSEcCtD
Dihydroergotamine—Rhinitis—Triamcinolone—allergic rhinitis	0.0001	0.000862	CcSEcCtD
Dihydroergotamine—Asthenia—Montelukast—allergic rhinitis	0.0001	0.000862	CcSEcCtD
Dihydroergotamine—Rhinitis—Methylprednisolone—allergic rhinitis	0.0001	0.00086	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Dexamethasone—allergic rhinitis	9.96e-05	0.000857	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Betamethasone—allergic rhinitis	9.96e-05	0.000857	CcSEcCtD
Dihydroergotamine—Pharyngitis—Triamcinolone—allergic rhinitis	9.92e-05	0.000853	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Betamethasone—allergic rhinitis	9.9e-05	0.000852	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Dexamethasone—allergic rhinitis	9.9e-05	0.000852	CcSEcCtD
Dihydroergotamine—Nausea—Cetirizine—allergic rhinitis	9.89e-05	0.000851	CcSEcCtD
Dihydroergotamine—Pruritus—Montelukast—allergic rhinitis	9.88e-05	0.00085	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Betamethasone—allergic rhinitis	9.82e-05	0.000845	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Dexamethasone—allergic rhinitis	9.82e-05	0.000845	CcSEcCtD
Dihydroergotamine—Nausea—Flunisolide—allergic rhinitis	9.73e-05	0.000837	CcSEcCtD
Dihydroergotamine—Visual impairment—Methylprednisolone—allergic rhinitis	9.61e-05	0.000827	CcSEcCtD
Dihydroergotamine—Diarrhoea—Montelukast—allergic rhinitis	9.56e-05	0.000822	CcSEcCtD
Dihydroergotamine—Dizziness—Montelukast—allergic rhinitis	9.24e-05	0.000794	CcSEcCtD
Dihydroergotamine—Vomiting—Montelukast—allergic rhinitis	8.88e-05	0.000764	CcSEcCtD
Dihydroergotamine—Rash—Montelukast—allergic rhinitis	8.81e-05	0.000757	CcSEcCtD
Dihydroergotamine—Dermatitis—Montelukast—allergic rhinitis	8.8e-05	0.000757	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Prednisolone—allergic rhinitis	8.78e-05	0.000755	CcSEcCtD
Dihydroergotamine—Headache—Montelukast—allergic rhinitis	8.75e-05	0.000752	CcSEcCtD
Dihydroergotamine—Visual impairment—Dexamethasone—allergic rhinitis	8.74e-05	0.000752	CcSEcCtD
Dihydroergotamine—Visual impairment—Betamethasone—allergic rhinitis	8.74e-05	0.000752	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Hydrocortisone—allergic rhinitis	8.57e-05	0.000737	CcSEcCtD
Dihydroergotamine—Malaise—Prednisolone—allergic rhinitis	8.53e-05	0.000734	CcSEcCtD
Dihydroergotamine—Vertigo—Prednisolone—allergic rhinitis	8.5e-05	0.000731	CcSEcCtD
Dihydroergotamine—Malaise—Hydrocortisone—allergic rhinitis	8.33e-05	0.000717	CcSEcCtD
Dihydroergotamine—Vertigo—Hydrocortisone—allergic rhinitis	8.3e-05	0.000714	CcSEcCtD
Dihydroergotamine—Nausea—Montelukast—allergic rhinitis	8.3e-05	0.000713	CcSEcCtD
Dihydroergotamine—Hypertension—Prednisolone—allergic rhinitis	8.17e-05	0.000703	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Triamcinolone—allergic rhinitis	8.07e-05	0.000694	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methylprednisolone—allergic rhinitis	8.06e-05	0.000693	CcSEcCtD
Dihydroergotamine—Hypertension—Hydrocortisone—allergic rhinitis	7.98e-05	0.000686	CcSEcCtD
Dihydroergotamine—Discomfort—Prednisolone—allergic rhinitis	7.96e-05	0.000684	CcSEcCtD
Dihydroergotamine—Myalgia—Hydrocortisone—allergic rhinitis	7.87e-05	0.000677	CcSEcCtD
Dihydroergotamine—Malaise—Triamcinolone—allergic rhinitis	7.85e-05	0.000675	CcSEcCtD
Dihydroergotamine—Anxiety—Hydrocortisone—allergic rhinitis	7.84e-05	0.000674	CcSEcCtD
Dihydroergotamine—Malaise—Methylprednisolone—allergic rhinitis	7.83e-05	0.000673	CcSEcCtD
Dihydroergotamine—Vertigo—Triamcinolone—allergic rhinitis	7.82e-05	0.000672	CcSEcCtD
Dihydroergotamine—Vertigo—Methylprednisolone—allergic rhinitis	7.8e-05	0.000671	CcSEcCtD
Dihydroergotamine—Discomfort—Hydrocortisone—allergic rhinitis	7.77e-05	0.000668	CcSEcCtD
Dihydroergotamine—Oedema—Prednisolone—allergic rhinitis	7.72e-05	0.000664	CcSEcCtD
Dihydroergotamine—Shock—Prednisolone—allergic rhinitis	7.6e-05	0.000653	CcSEcCtD
Dihydroergotamine—Oedema—Hydrocortisone—allergic rhinitis	7.54e-05	0.000649	CcSEcCtD
Dihydroergotamine—Tachycardia—Prednisolone—allergic rhinitis	7.54e-05	0.000648	CcSEcCtD
Dihydroergotamine—Hypertension—Triamcinolone—allergic rhinitis	7.51e-05	0.000646	CcSEcCtD
Dihydroergotamine—Hypertension—Methylprednisolone—allergic rhinitis	7.5e-05	0.000645	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Prednisolone—allergic rhinitis	7.47e-05	0.000642	CcSEcCtD
Dihydroergotamine—Shock—Hydrocortisone—allergic rhinitis	7.42e-05	0.000638	CcSEcCtD
Dihydroergotamine—Myalgia—Triamcinolone—allergic rhinitis	7.41e-05	0.000637	CcSEcCtD
Dihydroergotamine—Myalgia—Methylprednisolone—allergic rhinitis	7.39e-05	0.000636	CcSEcCtD
Dihydroergotamine—Arthralgia—Methylprednisolone—allergic rhinitis	7.39e-05	0.000636	CcSEcCtD
Dihydroergotamine—Anxiety—Methylprednisolone—allergic rhinitis	7.37e-05	0.000633	CcSEcCtD
Dihydroergotamine—Tachycardia—Hydrocortisone—allergic rhinitis	7.36e-05	0.000633	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Betamethasone—allergic rhinitis	7.33e-05	0.00063	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Dexamethasone—allergic rhinitis	7.33e-05	0.00063	CcSEcCtD
Dihydroergotamine—Discomfort—Triamcinolone—allergic rhinitis	7.32e-05	0.000629	CcSEcCtD
Dihydroergotamine—Discomfort—Methylprednisolone—allergic rhinitis	7.3e-05	0.000628	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Hydrocortisone—allergic rhinitis	7.29e-05	0.000627	CcSEcCtD
Dihydroergotamine—Dry mouth—Triamcinolone—allergic rhinitis	7.24e-05	0.000623	CcSEcCtD
Dihydroergotamine—Anorexia—Hydrocortisone—allergic rhinitis	7.19e-05	0.000618	CcSEcCtD
Dihydroergotamine—Confusional state—Methylprednisolone—allergic rhinitis	7.14e-05	0.000614	CcSEcCtD
Dihydroergotamine—Malaise—Dexamethasone—allergic rhinitis	7.12e-05	0.000612	CcSEcCtD
Dihydroergotamine—Malaise—Betamethasone—allergic rhinitis	7.12e-05	0.000612	CcSEcCtD
Dihydroergotamine—Oedema—Triamcinolone—allergic rhinitis	7.1e-05	0.000611	CcSEcCtD
Dihydroergotamine—Vertigo—Dexamethasone—allergic rhinitis	7.09e-05	0.00061	CcSEcCtD
Dihydroergotamine—Vertigo—Betamethasone—allergic rhinitis	7.09e-05	0.00061	CcSEcCtD
Dihydroergotamine—Hypotension—Hydrocortisone—allergic rhinitis	7.05e-05	0.000606	CcSEcCtD
Dihydroergotamine—Shock—Triamcinolone—allergic rhinitis	6.99e-05	0.000601	CcSEcCtD
Dihydroergotamine—Insomnia—Prednisolone—allergic rhinitis	6.98e-05	0.000601	CcSEcCtD
Dihydroergotamine—Shock—Methylprednisolone—allergic rhinitis	6.97e-05	0.0006	CcSEcCtD
Dihydroergotamine—Paraesthesia—Prednisolone—allergic rhinitis	6.93e-05	0.000596	CcSEcCtD
Dihydroergotamine—Tachycardia—Triamcinolone—allergic rhinitis	6.93e-05	0.000596	CcSEcCtD
Dihydroergotamine—Tachycardia—Methylprednisolone—allergic rhinitis	6.92e-05	0.000595	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	6.87e-05	0.000591	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Triamcinolone—allergic rhinitis	6.87e-05	0.00059	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Methylprednisolone—allergic rhinitis	6.85e-05	0.000589	CcSEcCtD
Dihydroergotamine—Insomnia—Hydrocortisone—allergic rhinitis	6.82e-05	0.000587	CcSEcCtD
Dihydroergotamine—Hypertension—Dexamethasone—allergic rhinitis	6.82e-05	0.000586	CcSEcCtD
Dihydroergotamine—Hypertension—Betamethasone—allergic rhinitis	6.82e-05	0.000586	CcSEcCtD
Dihydroergotamine—Paraesthesia—Hydrocortisone—allergic rhinitis	6.77e-05	0.000582	CcSEcCtD
Dihydroergotamine—Myalgia—Dexamethasone—allergic rhinitis	6.72e-05	0.000578	CcSEcCtD
Dihydroergotamine—Myalgia—Betamethasone—allergic rhinitis	6.72e-05	0.000578	CcSEcCtD
Dihydroergotamine—Anxiety—Dexamethasone—allergic rhinitis	6.7e-05	0.000576	CcSEcCtD
Dihydroergotamine—Anxiety—Betamethasone—allergic rhinitis	6.7e-05	0.000576	CcSEcCtD
Dihydroergotamine—Discomfort—Dexamethasone—allergic rhinitis	6.64e-05	0.000571	CcSEcCtD
Dihydroergotamine—Discomfort—Betamethasone—allergic rhinitis	6.64e-05	0.000571	CcSEcCtD
Dihydroergotamine—Dyspepsia—Hydrocortisone—allergic rhinitis	6.64e-05	0.000571	CcSEcCtD
Dihydroergotamine—Hypotension—Methylprednisolone—allergic rhinitis	6.62e-05	0.000569	CcSEcCtD
Dihydroergotamine—Pain—Prednisolone—allergic rhinitis	6.6e-05	0.000568	CcSEcCtD
Dihydroergotamine—Decreased appetite—Hydrocortisone—allergic rhinitis	6.56e-05	0.000564	CcSEcCtD
Dihydroergotamine—Fatigue—Hydrocortisone—allergic rhinitis	6.5e-05	0.000559	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	6.47e-05	0.000556	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	6.46e-05	0.000555	CcSEcCtD
Dihydroergotamine—Pain—Hydrocortisone—allergic rhinitis	6.45e-05	0.000555	CcSEcCtD
Dihydroergotamine—Oedema—Betamethasone—allergic rhinitis	6.44e-05	0.000554	CcSEcCtD
Dihydroergotamine—Oedema—Dexamethasone—allergic rhinitis	6.44e-05	0.000554	CcSEcCtD
Dihydroergotamine—Insomnia—Triamcinolone—allergic rhinitis	6.42e-05	0.000552	CcSEcCtD
Dihydroergotamine—Insomnia—Methylprednisolone—allergic rhinitis	6.41e-05	0.000551	CcSEcCtD
Dihydroergotamine—Paraesthesia—Triamcinolone—allergic rhinitis	6.38e-05	0.000548	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Prednisolone—allergic rhinitis	6.36e-05	0.000547	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methylprednisolone—allergic rhinitis	6.36e-05	0.000547	CcSEcCtD
Dihydroergotamine—Shock—Dexamethasone—allergic rhinitis	6.34e-05	0.000545	CcSEcCtD
Dihydroergotamine—Shock—Betamethasone—allergic rhinitis	6.34e-05	0.000545	CcSEcCtD
Dihydroergotamine—Dyspnoea—Triamcinolone—allergic rhinitis	6.33e-05	0.000544	CcSEcCtD
Dihydroergotamine—Tachycardia—Betamethasone—allergic rhinitis	6.29e-05	0.000541	CcSEcCtD
Dihydroergotamine—Tachycardia—Dexamethasone—allergic rhinitis	6.29e-05	0.000541	CcSEcCtD
Dihydroergotamine—Dyspepsia—Triamcinolone—allergic rhinitis	6.25e-05	0.000538	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methylprednisolone—allergic rhinitis	6.24e-05	0.000536	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Betamethasone—allergic rhinitis	6.23e-05	0.000536	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Dexamethasone—allergic rhinitis	6.23e-05	0.000536	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Hydrocortisone—allergic rhinitis	6.21e-05	0.000534	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	6.17e-05	0.00053	CcSEcCtD
Dihydroergotamine—Anorexia—Dexamethasone—allergic rhinitis	6.14e-05	0.000528	CcSEcCtD
Dihydroergotamine—Anorexia—Betamethasone—allergic rhinitis	6.14e-05	0.000528	CcSEcCtD
Dihydroergotamine—Urticaria—Prednisolone—allergic rhinitis	6.13e-05	0.000528	CcSEcCtD
Dihydroergotamine—Fatigue—Triamcinolone—allergic rhinitis	6.12e-05	0.000527	CcSEcCtD
Dihydroergotamine—Fatigue—Methylprednisolone—allergic rhinitis	6.11e-05	0.000525	CcSEcCtD
Dihydroergotamine—Pain—Triamcinolone—allergic rhinitis	6.07e-05	0.000522	CcSEcCtD
Dihydroergotamine—Hypotension—Betamethasone—allergic rhinitis	6.02e-05	0.000518	CcSEcCtD
Dihydroergotamine—Hypotension—Dexamethasone—allergic rhinitis	6.02e-05	0.000518	CcSEcCtD
Dihydroergotamine—Urticaria—Hydrocortisone—allergic rhinitis	5.99e-05	0.000515	CcSEcCtD
Dihydroergotamine—Body temperature increased—Hydrocortisone—allergic rhinitis	5.96e-05	0.000513	CcSEcCtD
Dihydroergotamine—Abdominal pain—Hydrocortisone—allergic rhinitis	5.96e-05	0.000513	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	5.87e-05	0.000505	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	5.87e-05	0.000505	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Triamcinolone—allergic rhinitis	5.85e-05	0.000503	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methylprednisolone—allergic rhinitis	5.84e-05	0.000502	CcSEcCtD
Dihydroergotamine—Insomnia—Dexamethasone—allergic rhinitis	5.83e-05	0.000501	CcSEcCtD
Dihydroergotamine—Insomnia—Betamethasone—allergic rhinitis	5.83e-05	0.000501	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	5.79e-05	0.000498	CcSEcCtD
Dihydroergotamine—Paraesthesia—Betamethasone—allergic rhinitis	5.79e-05	0.000498	CcSEcCtD
Dihydroergotamine—Paraesthesia—Dexamethasone—allergic rhinitis	5.79e-05	0.000498	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Prednisolone—allergic rhinitis	5.69e-05	0.000489	CcSEcCtD
Dihydroergotamine—Dyspepsia—Betamethasone—allergic rhinitis	5.67e-05	0.000488	CcSEcCtD
Dihydroergotamine—Dyspepsia—Dexamethasone—allergic rhinitis	5.67e-05	0.000488	CcSEcCtD
Dihydroergotamine—Urticaria—Triamcinolone—allergic rhinitis	5.64e-05	0.000485	CcSEcCtD
Dihydroergotamine—Urticaria—Methylprednisolone—allergic rhinitis	5.63e-05	0.000484	CcSEcCtD
Dihydroergotamine—Body temperature increased—Triamcinolone—allergic rhinitis	5.61e-05	0.000483	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methylprednisolone—allergic rhinitis	5.6e-05	0.000482	CcSEcCtD
Dihydroergotamine—Decreased appetite—Betamethasone—allergic rhinitis	5.6e-05	0.000482	CcSEcCtD
Dihydroergotamine—Decreased appetite—Dexamethasone—allergic rhinitis	5.6e-05	0.000482	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Hydrocortisone—allergic rhinitis	5.56e-05	0.000478	CcSEcCtD
Dihydroergotamine—Fatigue—Betamethasone—allergic rhinitis	5.56e-05	0.000478	CcSEcCtD
Dihydroergotamine—Fatigue—Dexamethasone—allergic rhinitis	5.56e-05	0.000478	CcSEcCtD
Dihydroergotamine—Pain—Dexamethasone—allergic rhinitis	5.51e-05	0.000474	CcSEcCtD
Dihydroergotamine—Pain—Betamethasone—allergic rhinitis	5.51e-05	0.000474	CcSEcCtD
Dihydroergotamine—Asthenia—Hydrocortisone—allergic rhinitis	5.41e-05	0.000465	CcSEcCtD
Dihydroergotamine—Pruritus—Hydrocortisone—allergic rhinitis	5.34e-05	0.000459	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dexamethasone—allergic rhinitis	5.31e-05	0.000457	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Betamethasone—allergic rhinitis	5.31e-05	0.000457	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dexamethasone—allergic rhinitis	5.27e-05	0.000453	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Betamethasone—allergic rhinitis	5.27e-05	0.000453	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Triamcinolone—allergic rhinitis	5.23e-05	0.00045	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methylprednisolone—allergic rhinitis	5.22e-05	0.000449	CcSEcCtD
Dihydroergotamine—Diarrhoea—Hydrocortisone—allergic rhinitis	5.16e-05	0.000444	CcSEcCtD
Dihydroergotamine—Urticaria—Betamethasone—allergic rhinitis	5.12e-05	0.00044	CcSEcCtD
Dihydroergotamine—Urticaria—Dexamethasone—allergic rhinitis	5.12e-05	0.00044	CcSEcCtD
Dihydroergotamine—Dizziness—Prednisolone—allergic rhinitis	5.11e-05	0.000439	CcSEcCtD
Dihydroergotamine—Asthenia—Triamcinolone—allergic rhinitis	5.1e-05	0.000438	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dexamethasone—allergic rhinitis	5.09e-05	0.000438	CcSEcCtD
Dihydroergotamine—Abdominal pain—Betamethasone—allergic rhinitis	5.09e-05	0.000438	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dexamethasone—allergic rhinitis	5.09e-05	0.000438	CcSEcCtD
Dihydroergotamine—Body temperature increased—Betamethasone—allergic rhinitis	5.09e-05	0.000438	CcSEcCtD
Dihydroergotamine—Asthenia—Methylprednisolone—allergic rhinitis	5.08e-05	0.000437	CcSEcCtD
Dihydroergotamine—Pruritus—Triamcinolone—allergic rhinitis	5.02e-05	0.000432	CcSEcCtD
Dihydroergotamine—Pruritus—Methylprednisolone—allergic rhinitis	5.01e-05	0.000431	CcSEcCtD
Dihydroergotamine—Dizziness—Hydrocortisone—allergic rhinitis	4.99e-05	0.000429	CcSEcCtD
Dihydroergotamine—Rash—Prednisolone—allergic rhinitis	4.87e-05	0.000419	CcSEcCtD
Dihydroergotamine—Dermatitis—Prednisolone—allergic rhinitis	4.86e-05	0.000418	CcSEcCtD
Dihydroergotamine—Diarrhoea—Methylprednisolone—allergic rhinitis	4.85e-05	0.000417	CcSEcCtD
Dihydroergotamine—Headache—Prednisolone—allergic rhinitis	4.84e-05	0.000416	CcSEcCtD
Dihydroergotamine—Vomiting—Hydrocortisone—allergic rhinitis	4.8e-05	0.000412	CcSEcCtD
Dihydroergotamine—Rash—Hydrocortisone—allergic rhinitis	4.76e-05	0.000409	CcSEcCtD
Dihydroergotamine—Dermatitis—Hydrocortisone—allergic rhinitis	4.75e-05	0.000409	CcSEcCtD
Dihydroergotamine—Headache—Hydrocortisone—allergic rhinitis	4.72e-05	0.000406	CcSEcCtD
Dihydroergotamine—Dizziness—Triamcinolone—allergic rhinitis	4.7e-05	0.000404	CcSEcCtD
Dihydroergotamine—Dizziness—Methylprednisolone—allergic rhinitis	4.69e-05	0.000403	CcSEcCtD
Dihydroergotamine—Asthenia—Dexamethasone—allergic rhinitis	4.62e-05	0.000398	CcSEcCtD
Dihydroergotamine—Asthenia—Betamethasone—allergic rhinitis	4.62e-05	0.000398	CcSEcCtD
Dihydroergotamine—Nausea—Prednisolone—allergic rhinitis	4.59e-05	0.000394	CcSEcCtD
Dihydroergotamine—Pruritus—Betamethasone—allergic rhinitis	4.56e-05	0.000392	CcSEcCtD
Dihydroergotamine—Pruritus—Dexamethasone—allergic rhinitis	4.56e-05	0.000392	CcSEcCtD
Dihydroergotamine—Vomiting—Triamcinolone—allergic rhinitis	4.52e-05	0.000388	CcSEcCtD
Dihydroergotamine—Vomiting—Methylprednisolone—allergic rhinitis	4.51e-05	0.000387	CcSEcCtD
Dihydroergotamine—Nausea—Hydrocortisone—allergic rhinitis	4.48e-05	0.000385	CcSEcCtD
Dihydroergotamine—Rash—Triamcinolone—allergic rhinitis	4.48e-05	0.000385	CcSEcCtD
Dihydroergotamine—Dermatitis—Triamcinolone—allergic rhinitis	4.47e-05	0.000385	CcSEcCtD
Dihydroergotamine—Rash—Methylprednisolone—allergic rhinitis	4.47e-05	0.000384	CcSEcCtD
Dihydroergotamine—Dermatitis—Methylprednisolone—allergic rhinitis	4.46e-05	0.000384	CcSEcCtD
Dihydroergotamine—Headache—Triamcinolone—allergic rhinitis	4.45e-05	0.000383	CcSEcCtD
Dihydroergotamine—Headache—Methylprednisolone—allergic rhinitis	4.44e-05	0.000382	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dexamethasone—allergic rhinitis	4.41e-05	0.000379	CcSEcCtD
Dihydroergotamine—Diarrhoea—Betamethasone—allergic rhinitis	4.41e-05	0.000379	CcSEcCtD
Dihydroergotamine—Dizziness—Dexamethasone—allergic rhinitis	4.26e-05	0.000366	CcSEcCtD
Dihydroergotamine—Dizziness—Betamethasone—allergic rhinitis	4.26e-05	0.000366	CcSEcCtD
Dihydroergotamine—Nausea—Triamcinolone—allergic rhinitis	4.22e-05	0.000363	CcSEcCtD
Dihydroergotamine—Nausea—Methylprednisolone—allergic rhinitis	4.21e-05	0.000362	CcSEcCtD
Dihydroergotamine—Vomiting—Betamethasone—allergic rhinitis	4.1e-05	0.000352	CcSEcCtD
Dihydroergotamine—Vomiting—Dexamethasone—allergic rhinitis	4.1e-05	0.000352	CcSEcCtD
Dihydroergotamine—Rash—Betamethasone—allergic rhinitis	4.06e-05	0.000349	CcSEcCtD
Dihydroergotamine—Rash—Dexamethasone—allergic rhinitis	4.06e-05	0.000349	CcSEcCtD
Dihydroergotamine—Dermatitis—Dexamethasone—allergic rhinitis	4.06e-05	0.000349	CcSEcCtD
Dihydroergotamine—Dermatitis—Betamethasone—allergic rhinitis	4.06e-05	0.000349	CcSEcCtD
Dihydroergotamine—Headache—Dexamethasone—allergic rhinitis	4.04e-05	0.000347	CcSEcCtD
Dihydroergotamine—Headache—Betamethasone—allergic rhinitis	4.04e-05	0.000347	CcSEcCtD
Dihydroergotamine—Nausea—Betamethasone—allergic rhinitis	3.83e-05	0.000329	CcSEcCtD
Dihydroergotamine—Nausea—Dexamethasone—allergic rhinitis	3.83e-05	0.000329	CcSEcCtD
Dihydroergotamine—HTR1D—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.76e-05	0.0168	CbGpPWpGaD
Dihydroergotamine—HTR1B—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.72e-05	0.0164	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.64e-05	0.0157	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.63e-05	0.0155	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.6e-05	0.0152	CbGpPWpGaD
Dihydroergotamine—HTR2B—G alpha (q) signalling events—CYSLTR1—allergic rhinitis	1.52e-05	0.0145	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.5e-05	0.0143	CbGpPWpGaD
Dihydroergotamine—HTR6—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.41e-05	0.0134	CbGpPWpGaD
Dihydroergotamine—HTR1D—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.4e-05	0.0133	CbGpPWpGaD
Dihydroergotamine—HTR1B—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.37e-05	0.013	CbGpPWpGaD
Dihydroergotamine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	1.36e-05	0.013	CbGpPWpGaD
Dihydroergotamine—HTR1A—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.31e-05	0.0125	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.29e-05	0.0123	CbGpPWpGaD
Dihydroergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.28e-05	0.0123	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.28e-05	0.0122	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.25e-05	0.0119	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.22e-05	0.0116	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	1.19e-05	0.0114	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.18e-05	0.0112	CbGpPWpGaD
Dihydroergotamine—HTR6—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.1e-05	0.0105	CbGpPWpGaD
Dihydroergotamine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.1e-05	0.0105	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—IL13—allergic rhinitis	1.09e-05	0.0104	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	1.08e-05	0.0103	CbGpPWpGaD
Dihydroergotamine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.07e-05	0.0102	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—PTGDR2—allergic rhinitis	1.07e-05	0.0102	CbGpPWpGaD
Dihydroergotamine—HTR2B—G alpha (q) signalling events—TAC1—allergic rhinitis	1.07e-05	0.0102	CbGpPWpGaD
Dihydroergotamine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.07e-05	0.0102	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—PTGDR2—allergic rhinitis	1.06e-05	0.0101	CbGpPWpGaD
Dihydroergotamine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.06e-05	0.0101	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.04e-05	0.00994	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—PTGDR2—allergic rhinitis	1.04e-05	0.00993	CbGpPWpGaD
Dihydroergotamine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.04e-05	0.00988	CbGpPWpGaD
Dihydroergotamine—ADRA2A—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.03e-05	0.00982	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—IL13—allergic rhinitis	1.02e-05	0.00972	CbGpPWpGaD
Dihydroergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.01e-05	0.00961	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	1e-05	0.00955	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—PTGDR2—allergic rhinitis	9.78e-06	0.00933	CbGpPWpGaD
Dihydroergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	9.74e-06	0.00929	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	9.56e-06	0.00911	CbGpPWpGaD
Dihydroergotamine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	9.55e-06	0.00911	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	9.54e-06	0.0091	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	9.38e-06	0.00895	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—IL5—allergic rhinitis	8.72e-06	0.00832	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—CYSLTR1—allergic rhinitis	8.41e-06	0.00802	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—CYSLTR1—allergic rhinitis	8.35e-06	0.00796	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	8.19e-06	0.00781	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	8.18e-06	0.0078	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—CYSLTR1—allergic rhinitis	8.17e-06	0.00779	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—CCL11—allergic rhinitis	8.12e-06	0.00775	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—CCL11—allergic rhinitis	8.06e-06	0.00769	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—PTGDR2—allergic rhinitis	7.93e-06	0.00757	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	7.9e-06	0.00753	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—CCL11—allergic rhinitis	7.89e-06	0.00753	CbGpPWpGaD
Dihydroergotamine—HTR6—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	7.75e-06	0.00739	CbGpPWpGaD
Dihydroergotamine—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	7.69e-06	0.00733	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—CYSLTR1—allergic rhinitis	7.68e-06	0.00732	CbGpPWpGaD
Dihydroergotamine—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	7.53e-06	0.00718	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	7.5e-06	0.00715	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—CCL11—allergic rhinitis	7.41e-06	0.00707	CbGpPWpGaD
Dihydroergotamine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	7.09e-06	0.00676	CbGpPWpGaD
Dihydroergotamine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	7.07e-06	0.00675	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—IL10—allergic rhinitis	6.81e-06	0.00649	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	6.75e-06	0.00644	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	6.43e-06	0.00613	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—IL10—allergic rhinitis	6.38e-06	0.00608	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—PTGDR2—allergic rhinitis	6.24e-06	0.00595	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—CYSLTR1—allergic rhinitis	6.23e-06	0.00594	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	6.21e-06	0.00592	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—IL4—allergic rhinitis	6.2e-06	0.00591	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.06e-06	0.00578	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—CCL11—allergic rhinitis	6.01e-06	0.00573	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—PTGDR2—allergic rhinitis	6.01e-06	0.00573	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR ligand binding—TAC1—allergic rhinitis	5.9e-06	0.00563	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—PTGDR2—allergic rhinitis	5.89e-06	0.00561	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR ligand binding—TAC1—allergic rhinitis	5.86e-06	0.00559	CbGpPWpGaD
Dihydroergotamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	5.74e-06	0.00547	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR ligand binding—TAC1—allergic rhinitis	5.74e-06	0.00547	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	5.54e-06	0.00528	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—PTGDR2—allergic rhinitis	5.53e-06	0.00527	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—PTGDR2—allergic rhinitis	5.5e-06	0.00525	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—PTGDR2—allergic rhinitis	5.46e-06	0.00521	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR ligand binding—TAC1—allergic rhinitis	5.39e-06	0.00514	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—PTGDR2—allergic rhinitis	5.35e-06	0.0051	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—PTGDR2—allergic rhinitis	5.02e-06	0.00479	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	4.89e-06	0.00467	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.75e-06	0.00453	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—CCL11—allergic rhinitis	4.73e-06	0.00451	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.72e-06	0.0045	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.62e-06	0.0044	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.51e-06	0.0043	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	4.48e-06	0.00428	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR ligand binding—TAC1—allergic rhinitis	4.37e-06	0.00417	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.34e-06	0.00414	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.32e-06	0.00412	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.28e-06	0.00408	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.19e-06	0.004	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—CCL11—allergic rhinitis	4.17e-06	0.00398	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—CCL11—allergic rhinitis	4.14e-06	0.00394	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—PTGDR2—allergic rhinitis	4.07e-06	0.00388	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—CCL11—allergic rhinitis	4.05e-06	0.00386	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.94e-06	0.00376	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—CCL11—allergic rhinitis	3.81e-06	0.00363	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.52e-06	0.00336	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.52e-06	0.00336	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR ligand binding—TAC1—allergic rhinitis	3.43e-06	0.00327	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—TAC1—allergic rhinitis	3.34e-06	0.00318	CbGpPWpGaD
Dihydroergotamine—HTR1A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	3.33e-06	0.00318	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—TAC1—allergic rhinitis	3.31e-06	0.00316	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—PTGDR2—allergic rhinitis	3.25e-06	0.0031	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—TAC1—allergic rhinitis	3.24e-06	0.00309	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—PTGDR2—allergic rhinitis	3.22e-06	0.00307	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—PTGDR2—allergic rhinitis	3.2e-06	0.00305	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.2e-06	0.00305	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—PTGDR2—allergic rhinitis	3.16e-06	0.00301	CbGpPWpGaD
Dihydroergotamine—HTR6—GPCR downstream signaling—IL5—allergic rhinitis	3.1e-06	0.00296	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—CCL11—allergic rhinitis	3.09e-06	0.00294	CbGpPWpGaD
Dihydroergotamine—HTR1D—GPCR downstream signaling—IL5—allergic rhinitis	3.08e-06	0.00293	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—TAC1—allergic rhinitis	3.04e-06	0.0029	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—TAC1—allergic rhinitis	3.03e-06	0.00289	CbGpPWpGaD
Dihydroergotamine—HTR1B—GPCR downstream signaling—IL5—allergic rhinitis	3.01e-06	0.00287	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—TAC1—allergic rhinitis	3.01e-06	0.00287	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—PTGDR2—allergic rhinitis	2.97e-06	0.00283	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—TAC1—allergic rhinitis	2.94e-06	0.00281	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—IL5—allergic rhinitis	2.85e-06	0.00272	CbGpPWpGaD
Dihydroergotamine—HTR2B—GPCR downstream signaling—IL5—allergic rhinitis	2.83e-06	0.0027	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling by GPCR—IL5—allergic rhinitis	2.82e-06	0.00269	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling by GPCR—IL5—allergic rhinitis	2.79e-06	0.00266	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.77e-06	0.00264	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—TAC1—allergic rhinitis	2.76e-06	0.00264	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling by GPCR—IL5—allergic rhinitis	2.74e-06	0.00261	CbGpPWpGaD
Dihydroergotamine—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	2.6e-06	0.00248	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling by GPCR—IL5—allergic rhinitis	2.57e-06	0.00245	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CYSLTR1—allergic rhinitis	2.55e-06	0.00243	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CYSLTR1—allergic rhinitis	2.53e-06	0.00241	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.51e-06	0.00239	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CYSLTR1—allergic rhinitis	2.48e-06	0.00236	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—TAC1—allergic rhinitis	2.47e-06	0.00235	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—CCL11—allergic rhinitis	2.46e-06	0.00235	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—CCL11—allergic rhinitis	2.44e-06	0.00233	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—CCL11—allergic rhinitis	2.43e-06	0.00231	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—PTGDR2—allergic rhinitis	2.41e-06	0.00229	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—CCL11—allergic rhinitis	2.39e-06	0.00228	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CYSLTR1—allergic rhinitis	2.33e-06	0.00222	CbGpPWpGaD
Dihydroergotamine—HTR1A—GPCR downstream signaling—IL5—allergic rhinitis	2.3e-06	0.00219	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—CCL11—allergic rhinitis	2.25e-06	0.00214	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—TAC1—allergic rhinitis	2.24e-06	0.00214	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling by GPCR—IL5—allergic rhinitis	2.08e-06	0.00199	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—TAC1—allergic rhinitis	1.94e-06	0.00185	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—PTGDR2—allergic rhinitis	1.89e-06	0.0018	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.89e-06	0.0018	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—CCL11—allergic rhinitis	1.82e-06	0.00174	CbGpPWpGaD
Dihydroergotamine—ADRA2A—GPCR downstream signaling—IL5—allergic rhinitis	1.8e-06	0.00172	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TAC1—allergic rhinitis	1.79e-06	0.00171	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TAC1—allergic rhinitis	1.78e-06	0.00169	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—TAC1—allergic rhinitis	1.76e-06	0.00168	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TAC1—allergic rhinitis	1.74e-06	0.00166	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—IL5—allergic rhinitis	1.66e-06	0.00159	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—IL5—allergic rhinitis	1.65e-06	0.00157	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.65e-06	0.00157	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling by GPCR—IL5—allergic rhinitis	1.64e-06	0.00156	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TAC1—allergic rhinitis	1.63e-06	0.00156	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—IL5—allergic rhinitis	1.62e-06	0.00154	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	1.54e-06	0.00147	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—IL5—allergic rhinitis	1.52e-06	0.00145	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.48e-06	0.00141	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—CCL11—allergic rhinitis	1.43e-06	0.00137	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TAC1—allergic rhinitis	1.32e-06	0.00126	CbGpPWpGaD
Dihydroergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.28e-06	0.00122	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—IL5—allergic rhinitis	1.23e-06	0.00117	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—SMAD3—allergic rhinitis	1.17e-06	0.00112	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—SMAD3—allergic rhinitis	1.16e-06	0.00111	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—SMAD3—allergic rhinitis	1.14e-06	0.00108	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—SMAD3—allergic rhinitis	1.07e-06	0.00102	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TAC1—allergic rhinitis	1.04e-06	0.000993	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—IL5—allergic rhinitis	9.68e-07	0.000923	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—SMAD3—allergic rhinitis	8.67e-07	0.000826	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Hemostasis—TGFB1—allergic rhinitis	8.51e-07	0.000811	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—SMAD3—allergic rhinitis	6.81e-07	0.00065	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—NFKB1—allergic rhinitis	5.95e-07	0.000567	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—NFKB1—allergic rhinitis	5.91e-07	0.000563	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—NFKB1—allergic rhinitis	5.78e-07	0.000551	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—NFKB1—allergic rhinitis	5.43e-07	0.000518	CbGpPWpGaD
Dihydroergotamine—HTR6—Signaling Pathways—TGFB1—allergic rhinitis	4.96e-07	0.000473	CbGpPWpGaD
Dihydroergotamine—HTR1D—Signaling Pathways—TGFB1—allergic rhinitis	4.92e-07	0.000469	CbGpPWpGaD
Dihydroergotamine—HTR1B—Signaling Pathways—TGFB1—allergic rhinitis	4.82e-07	0.000459	CbGpPWpGaD
Dihydroergotamine—HTR2B—Signaling Pathways—TGFB1—allergic rhinitis	4.53e-07	0.000431	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—NFKB1—allergic rhinitis	4.41e-07	0.00042	CbGpPWpGaD
Dihydroergotamine—HTR1A—Signaling Pathways—TGFB1—allergic rhinitis	3.67e-07	0.00035	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—NFKB1—allergic rhinitis	3.46e-07	0.00033	CbGpPWpGaD
Dihydroergotamine—ADRA2A—Signaling Pathways—TGFB1—allergic rhinitis	2.88e-07	0.000275	CbGpPWpGaD
